Melatonin levels in drug-free patients with major depression from the southern hemisphere

Psychoneuroendocrinology

Volumn 31, Issue 6, 2006, Pages 761-768

  Carvalho, Livia A ^a   Gorenstein, Clarice ^b   Moreno, Ricardo A ^a   Markus, Regina P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Laboratory of Medical Investigation 23   (Brazil)

Author keywords

6 Sulphatoxymelatonin; Healthy volunteers; Human; Major depression; Melatonin; Southern hemisphere

Indexed keywords

MELATONIN; 6 HYDROXYMELATONIN O SULFATE; 6-SULFATOXYMELATONIN; DRUG DERIVATIVE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR DEPRESSION; MALE; METABOLITE; PRIORITY JOURNAL; SEASONAL VARIATION; VOLUNTEER; BRAZIL; CIRCADIAN RHYTHM; COMPARATIVE STUDY; GEOGRAPHY; HOSPITALIZATION; PHOTOPERIODICITY; PHYSIOLOGY; REFERENCE VALUE; SEASON; STATISTICAL ANALYSIS; URINE;

ADULT; BRAZIL; CIRCADIAN RHYTHM; DEPRESSIVE DISORDER, MAJOR; FEMALE; GEOGRAPHY; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MELATONIN; PHOTOPERIOD; REFERENCE VALUES; SEASONS; SEVERITY OF ILLNESS INDEX;

EID: 33746678017     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2006.02.010     Document Type: Article

References (42)

1. American Psychiatry Association. Diagnostic and statistical of mental disorders diagnostic and statistical of mental disorders (1994), APA Press, Inc., Washington, DC
2. Arendt J., Wirz-Justice A., and Bradtke J. Annual rhythm of serum melatonin in man. Neurosci. Lett. 7 (1977) 327-330
3. Beck-Friis J., Kjellman B.F., Aperia B., Unden F., von Rosen D., Ljunggren J.G., and Wetterberg L. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta Psychiatr. Scand. 71 (1985) 319-330
4. Brown R., Kocsis J.H., Caroff S., Amsterdam J., Winokur A., Stokes P.E., and Frazer A. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am. J. Psychiatry 142 (1985) 811-816
5. Claustrat B., Chazot G., Brun J., Jordan D., and Sassolas G. A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol. Psychiatry 19 (1984) 1215-1228
6. Cook M.R., Graham C., Kavet R., Stevens R.G., Davis S., and Kheifets L. Morning urinary assessment of nocturnal melatonin secretion in older women. J. Pineal Res. 28 (2000) 41-47
7. Copinschi G., Van Onderbergen A., L'Hermite-Baleriaux M., Szyper M., Caufriez A., Bosson D., L'Hermite M., Robyn C., Turek F.W., and Van Cauter E. Effects of the short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep-related hormonal profiles in normal men. Sleep 13 (1990) 232-244
8. Crasson M., Kjiri S., Colin A., Kjiri K., L'Hermite-Baleriaux M., Ansseau M., and Legros J.J. Serum melatonin and urinary 6-sulfatoxymelatonin in major depression. Psychoneuroendocrinology 29 (2004) 1-12
9. Demisch L. Clinical pharmacology of melatonin regulation. In: Yu H.-S.R.R.J. (Ed). Melatonin, Biosynthesis, Physiological Effects and Clinical Applications (1993), CRC Press, Boca Raton, FL 513-540
10. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. Structured clinical interview for DSM-IV axis I disorders-patient edition, version 2.0 (SCID-I/P) (1995), Biometrics Research Department
11. Gibbons R.D., Davis J.M., and Hedeker D.R. A comment on the selection of 'healthy controls' for psychiatric experiments. Arch. Gen. Psychiatry 47 (1990) 785-786
12. Gorenstein C., Lotufo-Neto F., Melo M., Lauriano V., Guerra D.A., and Gentil V. Untreated psychopathology of candidates to normal volunteers. J. Clin. Psychopharmacol. 17 (1997) 238-239
13. Gorenstein C., Gentil V., Melo M., Lotufo-Neto F., and Lauriano V. Mood improvement in 'normal' volunteers. J. Psychopharmacol. 12 (1998) 246-251
14. Graham C., Cook M.R., Kavet R., Sastre A., and Smith D.K. Prediction of nocturnal plasma melatonin from morning urinary measures. J. Pineal Res. 24 (1998) 230-238
15. Griefahn B., Brode P., Blaszkewicz M., and Remer T. Melatonin production during childhood and adolescence: a longitudinal study on the excretion of urinary 6-hydroxymelatonin sulfate. J. Pineal Res. 34 (2003) 26-31
16. Guy M. Clinical global impressions. ECDEU Assessment Manual for Psychopharmacology Revised-DHEW (1976), Government Printing Office, Washington, DC (Publication number ADM 76-338)
17. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
18. Harding T.W., de Arango M.V., Baltazar J., Climent C.E., Ibrahim H.H., Ladrido-Ignacio L., Murthy R.S., and Wig N.N. Mental disorders in primary health care: a study of their frequency and diagnosis in four developing countries. Psychol. Med. 10 (1980) 231-241
19. Hartter S., Wang X., Weigmann H., Friedberg T., Arand M., Oesch F., and Hiemke C. Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin. J. Clin. Psychopharmacol. 21 (2001) 167-174
20. Klante G., Brinschwitz T., Secci K., Wollnik F., and Steinlechner S. Creatinine is an appropriate reference for urinary sulphatoxymelatonin of laboratory animals and humans. J. Pineal Res. 23 (1997) 191-197
21. Kripke D.F., Youngstedt S.D., Rex K.M., Klauber M.R., and Elliott J.A. Melatonin excretion with affect disorders over age 60. Psychiatry Res. 118 (2003) 47-54
22. Kripke D.F., Jean-Louis G., Elliott J.A., Klauber M.R., Rex K.M., Tuunainen A., and Langer R.D. Ethnicity, sleep, mood, and illumination in postmenopausal women. BMC Psychiatry 4 (2004) 8
23. Mari J.J., and Williams P. A validity study of a psychiatric screening questionnaire (SRQ-20) in primary care in the city of Sao Paulo. Br. J. Psychiatry 148 (1986) 23-26
24. Miller H.L., Ekstrom R.D., Mason G.A., Lydiard R.B., and Golden R.N. Noradrenergic function and clinical outcome in antidepressant pharmacotherapy. Neuropsychopharmacology 24 (2001) 617-623
25. Monteleone P., Forziati D., Orazzo C., and Maj M. Preliminary observations on the suppression of nocturnal plasma melatonin levels by short-term administration of diazepam in humans. J. Pineal Res. 6 (1989) 253-258
26. Nair N.P., Hariharasubramanian N., and Pilapil C. Circadian rhythm of plasma melatonin in endogenous depression. Prog. Neurol. Biol. Psychiatry 8 (1984) 715-718
27. Ostrowska Z., Zwirska-Korczala K., Buntner B., Pardela M., and Drozdz M. Association of body mass and body fat distribution with serum melatonin levels in obese women either non-operated or after jejunoileostomy. Endocr. Regul. 30 (1996) 33-40
28. Paparrigopoulos T. Melatonin response to atenolol administration in depression: indication of beta-adrenoceptor dysfunction in a subtype of depression. Acta Psychiatr. Scand. 106 (2002) 440-445
29. Paykel E.S. The hamilton scales. In: Bech P., and Coppen A. (Eds). The Hamilton Scales (1999), Springer, New York
30. Penny R., Stanczyk F., and Goebelsmann U. Melatonin: data consistent with a role in controlling ovarian function. J. Endocrinol. Invest. 10 (1987) 499-505
31. Rabe-Jablonska J., and Szymanska A. Diurnal profile of melatonin secretion in the acute phase of major depression and in remission. Med. Sci. Monit. 7 (2001) 946-952
32. Rubin R.T., Heist E.K., McGeoy S.S., Hanada K., and Lesser I.M. Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects. Arch. Gen. Psychiatry 49 (1992) 558-567
33. Sekula L.K., Lucke J.F., Heist E.K., Czambel R.K., and Rubin R.T. Neuroendocrine aspects of primary endogenous depression. XV: mathematical modeling of nocturnal melatonin secretion in major depressives and normal controls. Psychiatry Res. 69 (1997) 143-153
34. Shafii M., MacMillan D.R., Key M.P., Derrick A.M., Kaufman N., and Nahinsky I.D. Nocturnal serum melatonin profile in major depression in children and adolescents. Arch. Gen. Psychiatry 53 (1996) 1009-1013
35. Szymanska A., Rabe-Jablonska J., and Karasek M. Diurnal profile of melatonin concentrations in patients with major depression: relationship to the clinical manifestation and antidepressant treatment. Neuro. Endocrinol. Lett. 22 (2001) 192-198
36. Thompson C., Franey C., Arendt J., and Checkley S.A. A comparison of melatonin secretion in depressed patients and normal subjects. Br. J. Psychiatry 152 (1988) 260-265
37. Voderholzer U., Laakmann G., Becker U., Haag C., Baghai T., Riemann D., and Demisch L. Circadian profiles of melatonin in melancholic depressed patients and healthy subjects in relation to cortisol secretion and sleep. Psychiatry Res. 71 (1997) 151-161
38. von Bahr C., Ursing C., Yasui N., Tybring G., Bertilsson L., and Rojdmark S. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin. Eur. J. Clin. Pharmacol. 56 (2000) 123-127
39. Wehr T.A., Aeschbach D., and Duncan Jr. W.C. Evidence for a biological dawn and dusk in the human circadian timing system. J. Physiol. 535 (2001) 937-951
40. Weissman M.M., Wickramaratne P., Adams P., Wolk S., Verdeli H., and Olfson M. Brief screening for family psychiatric history: the family history screen. Arch. Gen. Psychiatry 57 (2000) 675-682
41. Wetterberg L., Bergiannaki J.D., Paparrigopoulos T., von Knorring L., Eberhard G., Bratlid T., and Yuwiler A. Normative melatonin excretion: a multinational study. Psychoneuroendocrinology 24 (1999) 209-226
42. Wetterberg L., Bratlid T., von Knorring L., Eberhard G., and Yuwiler A. A multinational study of the relationships between nighttime urinary melatonin production, age, gender, body size, and latitude. Eur. Arch. Psychiatry Clin. Neurosci. 249 (1999) 256-262